Processing your request


please wait...

Case Page

 

Case Status:    ONGOING    
On or around 12/22/2020 (Date of last review)

Filing Date: December 18, 2020

According to the Complaint, GoodRx Holdings, Inc. is a holding company that owns and operates a U.S. consumer-focused digital healthcare platform.

On August 28, 2020, GoodRx filed with the SEC a Form S-1 Registration Statement for its initial public offering, which was declared effective by the SEC on September 22, 2020. On September 24, 2020, GoodRx filed with the SEC its Prospectus for the IPO offering to sell to the public over 23.4 million Class A shares by the Company (excluding the underwriters’ option to purchase an additional 5.2 million common shares) and 11.2 million common shares by certain selling stockholders. On September 25, 2020, GoodRx closed its IPO. In the offering, the Company and certain existing stockholders sold over 39.8 million common shares for $33 per share, including the full exercise of the underwriters’ option, generating over $1.3 billion in gross offering proceeds.

The Complaint alleges that, at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx and that given Defendants' knowledge of Amazon’s intention to enter the online pharmaceutical business, their statements in the Registration Statement and during the Class Period about GoodRx’s competitive position were materially false and/or misleading when made.

COMPANY INFORMATION:

Sector: Technology
Industry: Software & Programming
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: GDRX
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: C.D. California
DOCKET #: 20-CV-11444
JUDGE: Hon. Dean D. Pregerson
DATE FILED: 12/18/2020
CLASS PERIOD START: 09/23/2020
CLASS PERIOD END: 11/16/2020
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Johnson Fistel, LLP
  2. Robbins Geller Rudman & Dowd LLP (San Diego)
No Document Title Filing Date
—Reference Complaint Complaint Related Data is not available
—Related District Court Filings Data is not available